Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients Caregivers Providers
Log In Ask a Question
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Lipidology

Building Your Specialized Care Team

At a Glance

Managing Dysbetalipoproteinemia (DBL) requires a multidisciplinary care team led by a clinical lipidologist. Because standard cholesterol tests are often inaccurate for DBL, these specialists use advanced markers to track remnant particles and treat underlying metabolic triggers.

Managing Dysbetalipoproteinemia (DBL) requires more than a standard approach to high cholesterol. Because the condition is a complex interaction between genetics and metabolism, your care often requires a team of specialists who understand how to target “remnant” particles rather than just LDL [1][2].

Your Core Care Team

A “multidisciplinary” approach—one that uses several types of experts—is the gold standard for DBL [3][4].

  • The Lipidologist: This is the most important specialist for DBL. A board-certified Clinical Lipidologist is a doctor specifically trained to manage complex cholesterol and triglyceride disorders [1][5]. They understand the specialized lab tests needed to track remnants [2].
  • The Endocrinologist: Since DBL is often “triggered” by metabolic issues like insulin resistance, diabetes, or thyroid problems, an endocrinologist helps manage these “second hits” to ensure your lipid medications work effectively [1][6].
  • The Cardiologist: Given the high risk of premature heart and vascular disease, a cardiologist monitors the health of your arteries and may perform screenings like the Ankle-Brachial Index (ABI) to check for leg artery issues [1][7].
  • The Genetic Counselor: If your diagnosis was confirmed via genetic testing, a counselor can help you understand the APOE results and help you navigate “cascade screening”—testing your children or siblings for the same genetic markers [8][9].

How to Vet Your Specialist

Not every doctor is familiar with the nuances of Type III Hyperlipoproteinemia. When meeting a new specialist, you can evaluate their expertise by asking:

  1. “Do you use the non-HDL-C to ApoB ratio to track my progress?” Experts know that standard LDL math is often inaccurate in DBL and rely on these more modern markers [10][11].
  2. “How many DBL/Type III patients do you treat?” Because DBL is often underdiagnosed, you want a specialist who has seen enough cases to recognize the specific physical and lab patterns of the disease [1].
  3. “Do you have access to specialized testing like beta-quantification?” While not always needed for daily monitoring, access to advanced lab work is a sign of a high-level lipid center [2][5].

Preparing for Your First Visit

To get the most out of your first appointment with a lipidologist, you should bring a “DBL Portfolio” [12][2]:

  • Historical Lipid Panels: Bring as many past blood tests as possible. Specialists look for the “equal” elevation of cholesterol and triglycerides over time [2][5].
  • Genetic Results: If you have had an APOE test, bring the full lab report, as it will specify if you have the classic e2/e2 profile or a rarer variant [8].
  • A “Lipid Family Tree”: Document any relatives who had heart attacks, strokes, or leg artery surgeries (stents or bypasses) before age 55 (men) or 65 (women) [9].
  • Current Metabolic Labs: Bring recent tests for your thyroid (TSH), blood sugar (A1c), and kidney function [13][14].

By assembling a team that understands the “remnant” nature of your condition, you shift from simply “managing numbers” to proactively protecting your vascular health [3].

Common questions in this guide

Which type of doctor is best for managing Dysbetalipoproteinemia?
A board-certified clinical lipidologist is the most important specialist for managing Dysbetalipoproteinemia. They have specialized training in complex cholesterol and triglyceride disorders and understand how to properly track remnant particles rather than just standard LDL.
Why might I need an endocrinologist for my DBL care?
Dysbetalipoproteinemia is often triggered by metabolic conditions like insulin resistance, diabetes, or thyroid issues. An endocrinologist helps manage these underlying triggers to ensure your lipid medications work as effectively as possible.
What role does a cardiologist play in treating DBL?
Because the condition carries a high risk of premature heart and vascular disease, a cardiologist monitors the health of your arteries. They can perform specific screenings, such as checking for leg artery issues, to proactively protect your cardiovascular system.
How do specialists monitor my progress with Dysbetalipoproteinemia?
Instead of relying on standard LDL calculations, experts typically use specialized markers like the non-HDL-C to ApoB ratio. Some high-level lipid centers may also use an advanced lab test called beta-quantification to accurately measure your remnant cholesterol levels.
What should I bring to my first appointment with a lipid specialist?
You should bring your historical lipid panels to show how your cholesterol and triglyceride levels have changed over time. It is also important to provide any APOE genetic testing results, recent metabolic lab work, and a family history of heart or vascular disease.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Are you board-certified by the American Board of Clinical Lipidology?
  2. 2.How many patients with Dysbetalipoproteinemia (Type III Hyperlipoproteinemia) do you currently manage?
  3. 3.Do you prefer to use the non-HDL-C to ApoB ratio or ultracentrifugation (beta-quantification) to monitor my remnant levels?
  4. 4.Can you help me coordinate my care with an endocrinologist to manage my 'second hit' triggers like insulin resistance?
  5. 5.Do you have a registered dietitian on your team who understands the specific low-carb needs of DBL patients?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (14)
  1. 1

    Familial dysbetalipoproteinemia: an underdiagnosed lipid disorder.

    Koopal C, Marais AD, Visseren FL

    Current opinion in endocrinology, diabetes, and obesity 2017; (24(2)):133-139 doi:10.1097/MED.0000000000000316.

    PMID: 28098593
  2. 2

    The clinical and laboratory investigation of dysbetalipoproteinemia.

    Boot CS, Luvai A, Neely RDG

    Critical reviews in clinical laboratory sciences 2020; (57(7)):458-469 doi:10.1080/10408363.2020.1745142.

    PMID: 32255405
  3. 3

    Hypertriglyceridaemia in pregnancy: an unexpected diagnosis and its management.

    Barclay K, Koysombat K, Padmagirison R, Kaplan F

    BMJ case reports 2022; (15(8)) doi:10.1136/bcr-2022-249000.

    PMID: 36038155
  4. 4

    Multidisciplinary teams in clinical lipidology and cardiometabolic care: A National Lipid Association Expert Clinical Review.

    Cheeley MK, Kirkpatrick CF, Brown EE, et al.

    Journal of clinical lipidology 2025; (19(4)):737-747 doi:10.1016/j.jacl.2025.05.002.

    PMID: 40483195
  5. 5

    The spectrum of type III hyperlipoproteinemia.

    Sniderman AD, de Graaf J, Thanassoulis G, et al.

    Journal of clinical lipidology 2018; (12(6)):1383-1389 doi:10.1016/j.jacl.2018.09.006.

    PMID: 30318453
  6. 6

    Adiposity and the development of dyslipidemia in APOE ε2 homozygous subjects: A longitudinal analysis in two population-based cohorts.

    Heidemann BE, Wolters FJ, Kavousi M, et al.

    Atherosclerosis 2021; (325()):57-62 doi:10.1016/j.atherosclerosis.2021.04.001.

    PMID: 33892328
  7. 7

    Dysbetalipoproteinemia Is Associated With Increased Risk of Coronary and Peripheral Vascular Disease.

    Paquette M, Bernard S, Baass A

    The Journal of clinical endocrinology and metabolism 2022; (108(1)):184-190 doi:10.1210/clinem/dgac503.

    PMID: 36056815
  8. 8

    Establishing the relationship between familial dysbetalipoproteinemia and genetic variants in the APOE gene.

    Heidemann BE, Koopal C, Baass A, et al.

    Clinical genetics 2022; (102(4)):253-261 doi:10.1111/cge.14185.

    PMID: 35781703
  9. 9

    Case Report: Hypertriglyceridemia and Premature Atherosclerosis in a Patient With Apolipoprotein E Gene ε2ε1 Genotype.

    Limonova AS, Ershova AI, Meshkov AN, et al.

    Frontiers in cardiovascular medicine 2020; (7()):585779 doi:10.3389/fcvm.2020.585779.

    PMID: 33537346
  10. 10

    Low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol measurement in Familial Dysbetalipoproteinemia.

    Heidemann BE, Koopal C, Roeters van Lennep JE, et al.

    Clinica chimica acta; international journal of clinical chemistry 2023; (539()):114-121 doi:10.1016/j.cca.2022.11.035.

    PMID: 36493875
  11. 11

    Type III Hyperlipoproteinemia: The Forgotten, Disregarded, Neglected, Overlooked, Ignored but Highly Atherogenic, and Highly Treatable Dyslipoproteinemia.

    Sniderman AD

    Clinical chemistry 2019; (65(2)):225-227 doi:10.1373/clinchem.2018.298026.

    PMID: 30538123
  12. 12

    Dysbetalipoproteinemia: Two cases report and a diagnostic algorithm.

    Kei A, Miltiadous G, Bairaktari E, et al.

    World journal of clinical cases 2015; (3(4)):371-6 doi:10.12998/wjcc.v3.i4.371.

    PMID: 25879010
  13. 13

    Genetic and Metabolic Factors of Familial Dysbetalipoproteinemia Phenotype: Insights from a Cross-Sectional Study.

    Blokhina AV, Ershova AI, Kiseleva AV, et al.

    International journal of molecular sciences 2025; (26(15)) doi:10.3390/ijms26157376.

    PMID: 40806502
  14. 14

    Postprandial Hyperlipidemia and Remnant Lipoproteins.

    Masuda D, Yamashita S

    Journal of atherosclerosis and thrombosis 2017; (24(2)):95-109 doi:10.5551/jat.RV16003.

    PMID: 27829582

This page provides educational information on assembling a care team for Dysbetalipoproteinemia. It is not a substitute for professional medical advice, diagnosis, or treatment from qualified healthcare providers.

Get notified when new evidence is published on Dysbetalipoproteinemia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.